Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia.

CONTEXT Lipase maturation factor 1 (LMF1) gene is a novel candidate gene in severe hypertriglyceridemia. Lmf1 is involved in the maturation of lipoprotein lipase (LPL) and hepatic lipase in endoplasmic reticulum. To date only one patient with severe hypertriglyceridemia and related disorders was found to be homozygous for a nonsense mutation in LMF1 gene (Y439X). OBJECTIVE The objective of the study was to investigate LMF1 gene in hypertriglyceridemic patients in whom mutations in LPL, APOC2, and APOA5 genes had been excluded. RESULTS The resequencing of LMF1 gene led to the discovery of a novel homozygous nonsense mutation in one patient with severe hypertriglyceridemia and recurrent episodes of pancreatitis. The mutation causes a G>A substitution in exon 9 (c.1395G>A), leading to a premature stop codon (W464X). LPL activity and mass were reduced by 76 and 50%, respectively, compared with normolipidemic controls. The proband over the years has shown a good response to treatment. The proband's son, heterozygous for the W464X, shows normal plasma triglyceride levels. CONCLUSIONS We identified the second novel pathogenic mutation in LMF1 gene in a patient with severe hypertriglyceridemia. LPL deficiency in our patient was milder than in the carrier of the Y439X previously described.

[1]  F. Yin,et al.  A quantitative assay measuring the function of lipase maturation factor 1 , 2009, Journal of Lipid Research.

[2]  S. Young,et al.  Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[3]  P. Pajukanta,et al.  Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia , 2007, Nature Genetics.

[4]  S. Yusuf,et al.  Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650) , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[5]  J. Brunzell,et al.  Clinical practice. Hypertriglyceridemia. , 2007, The New England journal of medicine.

[6]  P. Barter,et al.  Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[7]  R. Hegele,et al.  Hypertriglyceridemia: its etiology, effects and treatment , 2007, Canadian Medical Association Journal.

[8]  S. Young,et al.  Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. , 2007, Cell metabolism.

[9]  T. Olivecrona,et al.  Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue , 2006, Proceedings of the National Academy of Sciences.

[10]  H. Mao,et al.  The cld mutation: narrowing the critical chromosomal region and selecting candidate genes , 2006, Mammalian Genome.

[11]  S. Bertolini,et al.  A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. , 2006, Atherosclerosis.

[12]  L. Pennacchio,et al.  Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. , 2005, The Journal of clinical investigation.

[13]  G. Livolti,et al.  Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia , 2005 .

[14]  A. Cantafora,et al.  Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[15]  Kenichi Yoshida,et al.  Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.C200010-JLR200 , 2002, Journal of Lipid Research.

[16]  H. Mao,et al.  Maturation of Lipoprotein Lipase in the Endoplasmic Reticulum , 2002, The Journal of Biological Chemistry.

[17]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[18]  M. Doolittle,et al.  cld and lec23 are disparate mutations that affect maturation of lipoprotein lipase in the endoplasmic reticulum. , 1999, Journal of lipid research.

[19]  K. Reue,et al.  Naturally occurring mutations in mice affecting lipid transport and metabolism. , 1996, Journal of lipid research.

[20]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[21]  M. Taskinen Lipoprotein lipase in diabetes. , 1987, Diabetes/metabolism reviews.

[22]  K. Artzt,et al.  Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. , 1983, Science.

[23]  P. Kinnunen,et al.  An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[24]  S. Lehnart,et al.  Why Do We Still Have a Maternally Inherited Mitochondrial DNA ? Insights from Evolutionary Medicine , 2007 .